UK Markets closed

Mereo BioPharma Group plc (MREO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.8324-0.0048 (-0.57%)
At close: 04:00PM EST
0.8500 +0.02 (+2.11%)
After hours: 04:10PM EST
Full screen
Loading interactive chart…
  • Zacks

    MEREO BIOPHARMA (MREO) Loses 25.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

    The heavy selling pressure might have exhausted for MEREO BIOPHARMA (MREO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

  • Globe Newswire

    Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

    LONDON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 15, 2022 at 12:55pm GMT / 07:55am ET. A live audio webcast of the fireside chat can be accessed through the Investors sectio

  • Globe Newswire

    Mereo BioPharma Received Notification of Nasdaq Minimum Bid Price Deficiency

    LONDON, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced that on November 1, 2022, it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that its American Depositary Shares (“ADSs”) failed to maintain a minimum bid price of $1.00 over the previous 30 consecut